[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@DrSGraff Stephanie Graff, MD, FACP, FASCOStephanie Graff, MD, FACP, FASCO posts on X about remarkable, san antonio, ai, events the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence luxury brands #3242 technology brands
Social topic influence remarkable #498, san antonio #521, ai, events, soc, topics, the first, social media, science, finish
Top accounts mentioned or mentioned by @oncoalert @asco @sabcssanantonio @brownucancer @sgbcc @myesmo @erikahamilton9 @drhburstein @oncbrothers @curijoey @jcoasco @narjustflorezmd @hoperugo @tmprowell @drrshatsky @brownmedicine @ascopres @stolaney1 @onclive @conquercancerfd
Top posts by engagements in the last XX hours
"#SABCS25 IS HERE What are u 👀 ASCENT07 Saci v chemo in postET HR+MBC HER2Climb05 HP +/- Tucatinib maintenance postTHP in HER2+MBC lidERA adj Giredestrant in eBC Updates: EMBER3 SERENA6 VIKTORIA-1 ELEVATE INSEMA Key subgroups: PATINA CNS TBCRC-056 & Olympian in gBRCA"
X Link 2025-12-09T15:04Z 21.3K followers, 4385 engagements
"Fantastic review of where we are in the ER+ MBC post CDK4/6i landscape by @MOliveira_MD #SABCS25 @SABCSSanAntonio @OncoAlert"
X Link 2025-12-09T21:02Z 21.3K followers, 5242 engagements
"What a remarkable trio of awardees 👏🏻👏🏻👏🏻👏🏻 @stolaney1 @benhopark @SABCSSanAntonio @OncoAlert #SABCS25"
X Link 2025-12-10T14:55Z 21.3K followers, 2295 engagements
"Giredestrant reduces the risk of invasive disease recurrence or death by XX% (6.7% vs. XXX% events) compared with SOC ET in early breast cancer @OncoAlert @SABCSSanAntonio @dradityabardia #SABCS25"
X Link 2025-12-10T18:05Z 21.3K followers, 2944 engagements
"Lisa Carey @DrLisaCarey says what we are all thinkingHOW MUCH IS IT GOING TO COST 🤑🤑🤑 #lidERA #SABCS25"
X Link 2025-12-10T18:20Z 21.3K followers, XXX engagements
"Patient advocate @amybeumer gives another master class on the patient experience #SABCS25 @SABCSSanAntonio @OncoAlert"
X Link 2025-12-10T20:23Z 21.3K followers, 1869 engagements
"Honored to be joining Alamo Breast Cancer Foundation #SABCS25 Hot Topics Mentor Sessions this evening"
X Link 2025-12-10T22:45Z 21.3K followers, XXX engagements
"1 week friends. Cant wait to see you @SABCSSanAntonio #SABCS25"
X Link 2025-12-01T14:58Z 21.3K followers, 4378 engagements
"Coming in at the finish line I just logged my donation for #DiagnoseAndTreats #HCWvsHunger Who else needs to get their hat ( Or is it plate 🍽) in the ring"
X Link 2025-12-03T02:55Z 21.3K followers, 4545 engagements
"Its really real now#SABCS25 Get the app. #SABCS25 @SABCSSanAntonio"
X Link 2025-12-03T23:55Z 21.3K followers, 2418 engagements
"One of the new best reasons to travel to @SABCSSanAntonio is to see my mentee @DrSAHaddad doing her fellowship here in San Antonio. #SABCS25"
X Link 2025-12-09T02:27Z 21.3K followers, 2611 engagements
"In a clinical/multiomics database collab between @flatironhealth and @carisls data shows differing mechanisms of CDK4/6 inhibitor resistance based on if patient is obese at baseline. #SABCS25 @OncoAlert"
X Link 2025-12-10T13:44Z 21.3K followers, XXX engagements
"And here is the overall Treatment tolerability for DB-09 🟢Not at all / A little bit 🌕Somewhat 🍊Quite a bit / Very much #SABCS25"
X Link 2025-12-10T20:04Z 21.3K followers, XXX engagements
"First X groups of fellows presenting their work this morning absolutely knocked our socks off although my group was obviously the best 😉 @OncLive #OncLiveFellowsForum #SABCS25"
X Link 2025-12-08T17:26Z 21.3K followers, 5866 engagements
"And here are the final X groups What a remarkable day. The future is bright @OncLive #SABCS25"
X Link 2025-12-09T00:26Z 21.3K followers, 1107 engagements
"The one & only @stolaney1 has been named the 2025 AACR Outstanding Investigator Award for Breast Cancer Research. Congratulations Dr Tolaney #SABCS25 @SABCSSanAntonio @DFCI_BreastOnc"
X Link 2025-12-09T00:28Z 21.3K followers, 4814 engagements
"That feeling when you make the slide of first speaker and all-star advocate @coffeemommy to kick off #SABCS25 🥰❤🥰❤ @SABCSSanAntonio"
X Link 2025-12-09T17:14Z 21.3K followers, XXX engagements
"The Breast Medical Oncology team is together at San Antonio Breast Cancer Symposium this week. Proud of this remarkable team of colleagues collaborators researchers clinicians and friends. #SABCS25 @BrownUCancer @BrownUnivHealth @SABCSSanAntonio"
X Link 2025-12-09T19:03Z 21.3K followers, 1460 engagements
"Dr @elmayermd with a @DrHBurstein slide on all our post CDK4/6 inhibitor trials #SABCS25"
X Link 2025-12-09T21:08Z 21.3K followers, 1578 engagements
"📢 Dr. @CarlosArteagaMD highlights the role of @NIH @theNCI funding in improving cancer outcomes in and speaks to work @AACR @SABCSSanAntonio and all of the #SABCS25 community is doing and can do to encourage continued federal funding of cancer research. @OncoAlert"
X Link 2025-12-10T15:05Z 21.3K followers, XXX engagements
"HER2CLIMB-05 shows addition of tucatinib to maintenance HP after median X cycles THP improved mPFS XXX mos to XXXX mos. Benefit more pronounced in HR- but HR+ benefits as well. #SABCS25 @ErikaHamilton9 @OncoAlert"
X Link 2025-12-10T15:46Z 21.3K followers, 6239 engagements
"While OS is immature a separation of the curves is an early favorable sign; signal that pts with baseline brain mets benefit; and side effects are the anticipated profile of tucatinib + HP #SABCS25"
X Link 2025-12-10T15:46Z 21.3K followers, XXX engagements
"In an exploratory analysis of ALTTO trial w/2651 pts shows AI vs SERM improved DFS (shown) and TTDR without differences in OS particularly among premenopausal pts. @matteolambe 10-yr DFS XXXX v XXXX% 10-yr TTDR XXXX v XXXX% 10-yr OS XXXX v XXXX% #SABCS25 @OncoAlert"
X Link 2025-12-10T16:18Z 21.3K followers, XXX engagements
"2 TILS presentations: 🔬TILS are prognostic. Pathologists AI or both can measure them continues to learn morecheck them out #SABCS25"
X Link 2025-12-10T16:58Z 21.3K followers, XXX engagements
"ctDNA dynamics from pherGain summarized from @hthrparsons beautifully 🚫Absence = excellent outcome 📉Clearance by cycle X associates with pCR #SABCS25"
X Link 2025-12-10T17:11Z 21.3K followers, XXX engagements
"👀 Multimodal artificial intelligence (Al) model integrating image clinical and molecular data for predicts early and late breast cancer recurrence in TAILORX with excellent concordance as compared to Oncotype DX from a single Digitized H&E slide. #SABCS25 @OncoAlert"
X Link 2025-12-10T17:37Z 21.3K followers, XXX engagements
"ASCENT-07 does not show an improved mPFS (primary endpoint) by BICR with 1L chemo therapy (after ET) for Sacituzumab v treatment of physicians choice @jhaveri_komal #SABCS25 @OncoAlert"
X Link 2025-12-10T17:48Z 21.3K followers, 1072 engagements
"ASCENT-03 QoL data shows a sustained improvement in physical functioning and no deterioration in QoL with GI side effects among patients with mTNBC #SABCS25"
X Link 2025-12-10T19:45Z 21.3K followers, XXX engagements
"TDXd QoL from DB11 How bothered are you by effects of cancer treatment Color scale: 🔴Very much 🍊Quite a bit 🌕Somewhat 🟢A little bit 🫑Not at all #SABCS25"
X Link 2025-12-10T19:57Z 21.3K followers, 3909 engagements
"@Dr_RShatsky Uh. More tolerable may be a bit over enthusiastic"
X Link 2025-12-10T19:59Z 21.3K followers, XXX engagements
"Interesting ctDNA data out of the PALLAS data set; additional analysis planned. @hthrparsons #SABCS25"
X Link 2025-12-10T23:10Z 21.3K followers, XXX engagements
"Using c-TRAK TN data another compelling look at ctDNA dynamics and critically the role of tissue free ctDNA assays #SABCS25"
X Link 2025-12-10T23:18Z 21.3K followers, XXX engagements
"PATINA demonstrates lower rates of CNS progression in both all pts and those with brain meta at baseline with the addition of palbociclib. @Otto_DFCI @OncoAlert #SABCS25"
X Link 2025-12-11T22:43Z 21.3K followers, 1815 engagements